Letter to the Editors: Concerning BLong-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al Response

被引：1
|
作者：
Lee, Youngmok [1 ]
Chou, Janice Y. [2 ]
Weinstein, David A. [1 ]
机构：
[1] Univ Connecticut, Hlth Ctr, Farmington, CT 06030 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Differentiat, Bethesda, MD USA
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2018年 / 41卷 / 06期
关键词：
PREVENTION; LIVER;
D O I：
10.1007/s10545-018-0249-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：915 / 915
页数：1
相关论文
共 46 条
  • [31] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 309 - 309
  • [32] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 333 - 333
  • [33] Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies
    Guziewicz, Karina E.
    Cideciyan, Artur V.
    Kendrick, Brian T.
    Dufour, Valerie L.
    Ruthel, Gordon
    Komaromy, Andras M.
    Iwabe, Simone
    Hauswirth, William
    Beltran, William A.
    Jacobson, Samuel G.
    Aguirre, Gustavo D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Sustained efficacy and safety up to 3.5 years in adults with glycogen storage disease type Ia (GSDIa): longer-term results from a phase 1/2 clinical trial of DTX401, an AAV8-mediated, liver-directed gene therapy
    Mitchell, J.
    Derks, T. G.
    Riba-Wolman, R.
    Rodriguez-Buritica, D. F.
    Ahmad, A.
    Pico, M. L. Couce
    Weinstein, D. A.
    Mitragotri, D.
    Crombez, E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A25 - A26
  • [35] Long-Term Correction of Glycogen Storage Disease Type III by AAV-Mediated Gene Therapy Using a Dual Promoter to Express Bacterial Pullulanase
    Lim, Jeong-A
    Choi, Su Jin
    Kishnani, Priya S.
    Sun, Baodong
    MOLECULAR THERAPY, 2022, 30 (04) : 119 - 120
  • [36] Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia (vol 15, pg 1253, 2007)
    Koeberl, Dwight D.
    Sun, Baodong
    Bird, Andrew
    Chen, Yuan-Tsong
    Oka, Kazuhiro
    Chan, Lawrence
    MOLECULAR THERAPY, 2007, 15 (11) : 2051 - 2051
  • [37] Nutritional management in adults with glycogen storage disease type Ia (GSDIa) enrolled in a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy
    Saavedra, H.
    Mount, M.
    Lipinski, S.
    Camba-Garea, M-J
    de Boer, F.
    Reineking, B.
    Rodriguez-Buritica, D. F.
    Riba-Wolman, R.
    Ahmad, A.
    Couce Pico, M. L.
    Derks, T. G.
    Mitchell, J.
    Weinstein, D. A.
    Lee, C.
    Valayannopoulos, V.
    Crombez, E.
    MOLECULAR GENETICS AND METABOLISM, 2022, 136 : S19 - S19
  • [38] Positive Cohort 1 Results from the Phase 1/2 Trial with AAV8-Mediated Liver-Directed Gene Therapy in Adults with Glycogen Storage Disease Type Ia
    Weinstein, David A.
    Ahmad, Ayesha
    Lee, Connie
    Poma, Allen
    Crombez, Eric
    MOLECULAR THERAPY, 2019, 27 (04) : 12 - 12
  • [39] Positive cohort 1 results from the phase 1/2, AAV8-mediated liver-directed gene therapy trial in glycogen storage disease type Ia (GSDIa)
    Derks, T. G.
    Martin-Hernandez, E.
    Ahmad, A.
    Rodriguez-Buritica, D.
    Mitchell, J.
    Lee, C.
    Poma, A.
    Crombez, E.
    Weinstein, D. A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A14 - A14
  • [40] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia (vol 13, pg 1281, 2006)
    Koeberl, D. D.
    Sun, B. D.
    Damodaran, T. V.
    Brown, T.
    Millington, D. S.
    Benjamin, D. K., Jr.
    Bird, A.
    Schneider, A.
    Hillman, S.
    Jackson, M.
    Beaty, R. M.
    Chen, Y. T.
    GENE THERAPY, 2006, 13 (19) : 1430 - 1430
12345